Optimal Just-in-Time Enrollment

Our Just-in-Time (JIT) enrollment augments your existing approach with pre-qualified sites and pre-qualified patients. Sites are activated only after we identify a qualified patient at the site. Then, we consent patients in just two weeks.

Benefits

Optimized efficiency and patient centricity

  • Performance: first patient consented within two weeks of patient identification accelerates overall study performance
  • Patient-Centric: exposing more trial options and cutting-edge therapies to patients in their local communities, all while reducing the time and money spent on activities which do not help our patients get well.
  • Diversity: JIT sites are concentrated in ethnically diverse areas, helping expand access to underserved, minority populations
  • Efficiency: improved efficiencies/volume through protocol stacking
  • Risk Management: mitigate risk from non-enrolling sites; risk mitigation strategy is available from day 1

Features

Community of 300 oncology sites, pre-contracted with CDAs in place:

  • 1,000 investigators treating 500,000 patients annually
  • Located where the patients are
  • 96% of sites are private practices or community hospitals, giving sponsors access to patients otherwise overlooked
  • 7+ years of industry clinical research experience
  • No site is paid until it is activated

Optimal Just-in-Time Enrollment service accesses the most advanced cancer treatment techniques available to patients using a network of community-based cancer treatment centers that conduct clinical research.

Patients participating in our studies receive:

Treatment they need

In the community where they live

From physicians they trust

Surrounded by people they love

Our Comprehensive Site Network

Our network of board-certified oncology and hematology specialists occupy state-of-the-art facilities where they conduct quality research in Phase 1 through Phase 4 programs while focusing on quality health management and compassionate care. Their collective therapeutic experience includes both solid and hematologic malignancies.

Our Approach to Patient Care

Enrolling the right patient into a research program is the goal to achieve quality data. To do this, we focus on patient education. When an individual is first diagnosed, or has failed treatment, they seek answers. Our physicians and research nurses are there to provide information, guidance, and comfort during this difficult time. Patients receive information specific to their disease state, current methods of treatment, and treatment options. We accomplish this through use of local oncologists, information packets, web-based education, and connecting patients to advocacy groups to ensure that their questions are answered and their needs are met.